Edwards Lifesciences Corporation Stock price

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-02-21 pm EST 5-day change 1st Jan Change
86.65 USD -0.29% Intraday chart for Edwards Lifesciences Corporation +0.71% +13.64%
Sales 2024 * 6.52B Sales 2025 * 7.16B Capitalization 52.1B
Net income 2024 * 1.63B Net income 2025 * 1.83B EV / Sales 2024 * 7.65 x
Net cash position 2024 * 2.23B Net cash position 2025 * 3.62B EV / Sales 2025 * 6.77 x
P/E ratio 2024 *
32.1 x
P/E ratio 2025 *
28.7 x
Employees 19,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.6%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Edwards Lifesciences Corporation

1 day-0.29%
1 week+0.71%
Current month+10.42%
1 month+16.61%
3 months+29.41%
6 months+13.52%
Current year+13.64%
More quotes
1 week
85.30
Extreme 85.3
87.25
1 month
71.92
Extreme 71.92
90.20
Current year
71.67
Extreme 71.67
90.20
1 year
60.57
Extreme 60.57
94.87
3 years
60.57
Extreme 60.57
131.73
5 years
51.51
Extreme 51.5067
131.73
10 years
11.14
Extreme 11.1433
131.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14-12-31
Chairman 71 99-12-31
Director of Finance/CFO 57 13-12-31
Members of the board TitleAgeSince
Director/Board Member 63 16-07-04
Director/Board Member 67 14-11-12
Director/Board Member 72 16-03-15
More insiders
Date Price Change Volume
24-02-21 86.65 -0.29% 2,142,405
24-02-20 86.9 +0.93% 3,235,818
24-02-16 86.1 +0.07% 2,122,134
24-02-15 86.04 0.00% 2,727,306
24-02-14 86.04 -0.26% 4,976,605

Delayed Quote Nyse, February 21, 2024 at 04:00 pm EST

More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - hemodynamic monitoring systems (65.4%); - heart valves and surgery products (18.7%); - other (15.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.65 USD
Average target price
91.18 USD
Spread / Average Target
+5.23%
Consensus
  1. Stock
  2. Equities
  3. Stock Edwards Lifesciences Corporation - Nyse
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer